Literature DB >> 17033757

Linezolid therapy of bloodborne teicoplanin-resistant Staphylococcus haemolyticus.

I Mohammedi, S Malhière, D Robert, M A Charveriat, J Etienne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17033757     DOI: 10.1007/s15010-006-5625-3

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  1 in total

1.  Antimicrobial resistance and molecular characterization of Staphylococcus haemolyticus in a Chinese hospital.

Authors:  M-H Yu; Y-G Chen; Y-S Yu; C-L Chen; L-J Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-04       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.